Peter Hall

Variation in chemotherapy prescribing rates and mortality in early breast cancer in Scotland. A national data linkage study - variation is reducing over the last 20 yrs @CancerDataEdin sciencedirect.com/science/articl…

Edinburgh Breast Cancer Specialist Symposium 2025 (EBCSS) 21-22 Feb was a great success. Excellent scientific programme, eminent speakers, brilliant talks and superb organisation. Hope to see you all again in Feb 2027

Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): a multicentre, randomised, phase 3, non-inferiority trial - The Lancet thelancet.com/journals/lance…

#SABCS24 FDA session highlighting need to consider Minimum Effictive Dose, not just Maximum Tolerated Dose. Reminds me of the GO2 trial last decade. Breast cancer drug development catching up? jamanetwork.com/journals/jamao…

Find me on bsky.app/profile/peterh…

RCT of the effect of the omega-3 polyunsaturated fatty acid EPA on colorectal cancer recurrence and survival after surgery for resectable liver metastases: EPA for Metastasis Trial 2 (EMT2) study protocol bmjopen.bmj.com/content/13/11/…

Having a break from Twitter

@DanHannard I do like a nice parhelion

Bonus holiday Physics: sun dogs and a solar halo this evening! #chatphysics

Edinburgh Pain Assessment Tool EPAT results in prescription of less opioids but more adjuvant analgesics and non-pharmacological approaches. Reduces costs overall. spcare.bmj.com/cgi/rapidpdf/s…

@majbaxter @RussellPetty19 @drohanlon @kennycairns @AlanaBrown_Kerr @CSO_Scotland @TenovusScotland @UoDMedicine @NHSTayside Well deserved!

And thank you to everyone who has helped along the way! Especially @RussellPetty19, Dr Lindsay Spender, @PeterHall001 @drohanlon @kennycairns (and of course @AlanaBrown_Kerr!) @CSO_Scotland @TenovusScotland @UoDMedicine @NHSTayside

Excellent EBCSS 2023 meeting yesterday. Most well organised meeting with the best programme. Heartiest congratulations to the organising committee.

Great to see this out. First data from the SCCAMP study - we looked at COVID infection and vaccination status of patients with solid organ cancers undergoing active cancer treatment from the beginning of the pandemic, with longitudinal antibody serology doi.org/10.1093/oncolo…

Check it out! 👆👆👆Real world ongoing study that we are excited to build upon. Truly collaborative, supported by @EdinCRC @NHS_Lothian and an @EcatTrack collab in there too. @PeterHall001

If interested in #PancreaticCancer, #AI and #DataScience, please apply to join our team @precisionpanc @UofGCancerSci @CRUKScotland @EdinCRC @PeterHall001 👇 findaphd.com/phds/project/f…

Real-World Impact of SABR on Stage I Non-Small-Cell Lung Cancer Outcomes at a Scottish Cancer Centre mdpi.com/2157404 #mdpicancers via @Cancers_MDPI

“The Scottish COVID Cancer Immunity Prevalence Study: A Longitudinal Study of SARS-CoV-2 Immune Response in Patients Receiving Anti–Cancer Treatment” - work by @EdinCRC @EdinUni_IGC @CancerDataEdin investigators and colleagues published in @OncJournal 👇. doi.org/10.1093/oncolo…

🌟Day 01 - Summarising factors with finalfit🌟 #HealthyR #rstats: excerpts from our "R for Health Data Science" book! Comment: when did you last use summary_factorlist()? Any questions: @ewenharrison and myself happy to answer here! Book chapter here: argoshare.is.ed.ac.uk/healthyr_book/…

The protocol for our @HDR_UK project "Studying the Long term Impact of COVID in Kids" (SLICK) is now out in @BMJ_Open Brilliant team looking at healthcare use in the year after SARS-CoV-2 infection in children across the UK bmjopen.bmj.com/content/12/11/…

Reproductive history differs by molecular subtypes of breast cancer among women aged ≤ 50 years in Scotland diagnosed 2009–2016: a cross-sectional study link.springer.com/article/10.100…

Look out for us at Scottish Health Economics! @PeterHall001 @ElizabethLemm @bullen_ali & our fresh faced new starter Marek Atter are all attending in person!